Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma

Pai Pang, Hui Fang, Hong Wu, Song Wang, Minda Liu, Shan Jin, Zhongzheng Qi, Zhenning Li, Fayu Liu, Changfu SunBioengineered 2021 · DOI

TL;DR

Researchers have uncovered a novel positive feedback loop between the transcription factor SP1 and microRNA-92b (miR-92b) that drives the migration, invasion, and proliferation of head and neck squamous cell carcinoma (HNSCC). This SP1/miR-92b axis appears to be a key driver of HNSCC progression and metastasis, suggesting it could be a promising therapeutic target.

What Problem Does This Paper Address?

Head and neck squamous cell carcinoma (HNSCC) is a particularly aggressive cancer with a high rate of locoregional invasion and metastasis to cervical lymph nodes, leading to poor patient survival rates. Despite advances, a deeper understanding of the molecular mechanisms underlying HNSCC progression and metastasis is crucial for developing more effective treatments. While microRNAs (miRNAs) are known to play roles in cancer, the specific mechanisms by which miR-92b contributes to HNSCC invasion and migration, and its interaction with key regulatory proteins, remained unclear. This study aimed to elucidate the role of miR-92b and its potential interaction with the transcription factor SP1 in driving HNSCC metastasis.

Methods

The researchers employed a multi-pronged approach to investigate the SP1/miR-92b axis:

  • Gene Expression Analysis: Microarray and quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) were used to assess miR-92b expression levels in HNSCC tissues and cell lines, and to validate findings from microarray analysis.
  • Functional Assays: Standard in vitro assays were utilized to evaluate the impact of miR-92b and SP1 manipulation on cancer cell behavior:
  • Transwell migration and invasion assays: To measure the ability of cells to move through a membrane.
  • Wound healing assay: To assess the rate of cell migration and wound closure.
  • Cell Counting Kit-8 (CCK-8) assay: To determine cell proliferation and viability.
  • Molecular Mechanistic Studies:
    • Chromatin Immunoprecipitation (ChIP) assay: To confirm direct binding of SP1 to the miR-92b promoter region.
  • Western blot analysis: To detect protein levels of SP1.
  • In Vivo Studies: A xenograft model in nude mice was used to evaluate the effect of SP1 knockdown on tumor growth.
  • Bioinformatics Analysis: Publicly available HNSCC patient data from The Cancer Genome Atlas (TCGA) was analyzed to correlate miR-92b expression with clinical characteristics and survival.

Datasets

  • HNSCC Patient Specimens: 15 paired primary HNSCC focus and adjacent normal tissue samples were collected from patients treated at China Medical University.
  • HNSCC Cell Lines: PCI-4A/4B and PCI-37A/37B cell lines, derived from primary HNSCC foci and corresponding metastases, were used.
  • The Cancer Genome Atlas (TCGA) – HNSC database: Gene expression data and clinical information from 523 HNSCC patients were analyzed.

Key Insights and Ideas

  • miR-92b as a Driver of HNSCC Aggression: The study strongly implicates miR-92b as a key player in promoting HNSCC cell migration, invasion, and proliferation. Its elevated expression in metastatic tissues and correlation with higher clinical stages and poorer survival underscore its oncogenic role.
  • SP1 as a Regulator of miR-92b: The research provides compelling evidence that SP1 directly binds to the miR-92b promoter, driving its transcription. This establishes SP1 as a crucial upstream regulator of miR-92b.
  • A Novel Positive Feedback Loop: The most significant finding is the identification of a positive feedback loop where SP1 upregulates miR-92b, and in turn, miR-92b appears to promote SP1 expression (though the exact mechanism for this latter part is suggested to be indirect). This self-reinforcing loop amplifies the pro-metastatic effects.
  • Therapeutic Potential: The SP1/miR-92b axis emerges as a potential therapeutic target. Inhibiting this loop could offer a novel strategy to combat HNSCC invasion and metastasis.

Key Results

  • Elevated miR-92b in HNSCC: miR-92b expression was significantly higher in HNSCC primary tumors and metastatic lesions compared to adjacent normal tissues.
  • Correlation with Clinical Severity: Higher miR-92b levels were associated with advanced clinical stages (III&IV) and lymph node metastasis (N+).
  • Prognostic Significance: Patients with high miR-92b expression exhibited significantly lower survival rates.
  • SP1 Upregulates miR-92b: Knockdown of SP1 led to a significant decrease in miR-92b expression.
  • miR-92b Promotes Migration and Invasion: Ectopic expression of miR-92b enhanced cell migration and invasion, while its inhibition reduced these abilities.
  • SP1 Promotes Migration and Invasion: Knockdown of SP1 also significantly decreased cell migration and invasion.
  • In Vivo Tumor Growth Inhibition: SP1 knockdown in a xenograft model led to reduced tumor growth speed and volume.
  • Positive Feedback Confirmation: Transfection with miR-92b mimics or inhibitors resulted in parallel changes in SP1 mRNA and protein expression, supporting the feedback loop.

Limitations and Future Work

  • Indirect Regulation of SP1: While the study demonstrates that miR-92b influences SP1 expression, the precise indirect mechanism by which miR-92b upregulates SP1 levels is not fully elucidated. The authors suggest it might involve other intermediate elements.
  • CCR7 as a Downstream Target: The paper identifies chemokine receptor 7 (CCR7) as a likely downstream target of both SP1 and miR-92b. CCR7 is known to promote HNSCC metastasis. The authors propose that the SP1/miR-92b loop may promote HNSCC metastasis via CCR7 signaling, which warrants further investigation.
  • Further Mechanistic Elucidation: While the direct binding of SP1 to the miR-92b promoter was confirmed, a more detailed understanding of the entire regulatory network and the precise molecular interactions within the feedback loop could be explored.

The study successfully establishes the SP1/miR-92b feedback loop as a critical driver of HNSCC progression and metastasis, opening avenues for targeted therapeutic interventions.

Summary updated

Abstract

In this study we report a novel specificity protein 1 (SP1)/microRNA-92b (miR-92b) feedback loop regulating the migration and invasion of head and neck squamous cell carcinoma (HNSCC). Microarray and real-time Polymerase Chain Reaction (PCR) were used to detect gene expression in HNSCC tissues and cell lines. Transwell migration, invasion, wound healing and cell counting kit - 8 (CCK-8) cell assays were used to compare cell migration, invasion and proliferation abilities. Chromatin Immunoprecipitation (ChIP) assays were used to detect SP1 binding to the miR-92b promoter. Western blot was used to detect protein levels. An in vivo tumorigenesis experiment was used to evaluate the effect of SP1 knockdown on tumor growth and protein levels were evaluated by immunohistochemistry. We found that the miR-92b expression level was elevated in HNSCC primary focus tissue compared with adjacent normal tissue, and a higher level of miR-92b was related to a higher clinical stage and worse prognosis of HNSCC patients. MiR-92b and SP1 mutually promoted each expression and cooperatively facilitated the migration, invasion and proliferation of HNSCC cells. A decreased level of SP1/miR-92b resulted in a restraint of in vivo tumor growth. In conclusion, our results suggest that the SP1/miR-92b feedback loop generally promotes HNSCC invasion and metastasis, thus presenting a possible therapeutic target in the treatment of HNSCC patients.
BibTeX
@inproceedings{pang2021specificity,
  author = {Pai Pang and Hui Fang and Hong Wu and Song Wang and Minda Liu and Shan Jin and Zhongzheng Qi and Zhenning Li and Fayu Liu and Changfu Sun},
  title = {{Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma}},
  booktitle = {Bioengineered},
  year = {2021},
  doi = {10.1080/21655979.2021.2008698},
}
Figure